img

Global and United States Solid Dosage Form Drug Market Report & Forecast 2024-2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and United States Solid Dosage Form Drug Market Report & Forecast 2024-2034

Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
Market Analysis and InsightsGlobal and United States Solid Dosage Form Drug Market
This report focuses on global and United States Solid Dosage Form Drug market, also covers the segmentation data of other regions in regional level and county level.
The global Solid Dosage Form Drug revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the review period (2024-2034).
In United States the Solid Dosage Form Drug revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period 2024-2034.
The global key players of Solid Dosage Form Drug include Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer and Sanofi, etc. The global five biggest players hold a share of % in 2024.
Global Solid Dosage Form Drug Scope and Market Size
Solid Dosage Form Drug market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Solid Dosage Form Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2034.
For United States market, this report focuses on the Solid Dosage Form Drug market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in United States.



By Company


Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Teva
Boehringer Ingelheim
Biogen
Astellas
Segment by Type
Tablet
Capsules
Other

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Solid Dosage Form Drug definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Solid Dosage Form Drug companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Solid Dosage Form Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Solid Dosage Form Drug revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions

Table of Content

1 Study Coverage
1.1 Solid Dosage Form Drug Product Introduction
1.2 Global Solid Dosage Form Drug Outlook 2018 VS 2024 VS 2034
1.2.1 Global Solid Dosage Form Drug Market Size for the Year 2018-2034
1.2.2 United States Solid Dosage Form Drug Market Size for the Year 2018-2034
1.3 Solid Dosage Form Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.3.1 The Market Share of United States Solid Dosage Form Drug in Global, 2018 VS 2024 VS 2034
1.3.2 The Growth Rate of Solid Dosage Form Drug Market Size, United States VS Global, 2018 VS 2024 VS 2034
1.4 Solid Dosage Form Drug Market Dynamics
1.4.1 Solid Dosage Form Drug Industry Trends
1.4.2 Solid Dosage Form Drug Market Drivers
1.4.3 Solid Dosage Form Drug Market Challenges
1.4.4 Solid Dosage Form Drug Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Solid Dosage Form Drug by Type
2.1 Solid Dosage Form Drug Market Segment by Type
2.1.1 Tablet
2.1.2 Capsules
2.1.3 Other
2.2 Global Solid Dosage Form Drug Market Size by Type (2018, 2024 & 2034)
2.3 Global Solid Dosage Form Drug Market Size by Type (2018-2034)
2.4 United States Solid Dosage Form Drug Market Size by Type (2018, 2024 & 2034)
2.5 United States Solid Dosage Form Drug Market Size by Type (2018-2034)
3 Solid Dosage Form Drug by Application
3.1 Solid Dosage Form Drug Market Segment by Application
3.1.1 Hospital
3.1.2 Retail Pharmacy
3.1.3 Other
3.2 Global Solid Dosage Form Drug Market Size by Application (2018, 2024 & 2034)
3.3 Global Solid Dosage Form Drug Market Size by Application (2018-2034)
3.4 United States Solid Dosage Form Drug Market Size by Application (2018, 2024 & 2034)
3.5 United States Solid Dosage Form Drug Market Size by Application (2018-2034)
4 Global Solid Dosage Form Drug Competitor Landscape by Company
4.1 Global Solid Dosage Form Drug Market Size by Company
4.1.1 Global Key Companies of Solid Dosage Form Drug, Ranked by Revenue (2024)
4.1.2 Global Solid Dosage Form Drug Revenue by Player (2018-2023)
4.2 Global Solid Dosage Form Drug Concentration Ratio (CR)
4.2.1 Solid Dosage Form Drug Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Solid Dosage Form Drug in 2024
4.2.3 Global Solid Dosage Form Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Solid Dosage Form Drug Head office and Area Served
4.4 Global Key Players of Solid Dosage Form Drug, Product and Application
4.5 Global Key Players of Solid Dosage Form Drug, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 United States Solid Dosage Form Drug Market Size by Company
4.7.1 Key Players of Solid Dosage Form Drug in United States, Ranked by Revenue (2024)
4.7.2 United States Solid Dosage Form Drug Revenue by Players (2021, 2024 & 2023)
5 Global Solid Dosage Form Drug Market Size by Region
5.1 Global Solid Dosage Form Drug Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Solid Dosage Form Drug Market Size by Region (2018-2034)
5.2.1 Global Solid Dosage Form Drug Market Size by Region: 2018-2023
5.2.2 Global Solid Dosage Form Drug Market Size by Region (2024-2034)
6 Americas
6.1 Americas Solid Dosage Form Drug Market Size YoY Growth 2018-2034
6.2 Americas Solid Dosage Form Drug Market Size by Type
6.2.1 Americas Solid Dosage Form Drug Market Size by Type (2018-2023)
6.2.2 Americas Solid Dosage Form Drug Market Size by Type (2024-2034)
6.2.3 Americas Solid Dosage Form Drug Market Share by Type (2018-2034)
6.3 Americas Solid Dosage Form Drug Market Size by Application
6.3.1 Americas Solid Dosage Form Drug Market Size by Application (2018-2023)
6.3.2 Americas Solid Dosage Form Drug Market Size by Application (2024-2034)
6.3.3 Americas Solid Dosage Form Drug Market Share by Application (2018-2034)
6.4 Americas Solid Dosage Form Drug Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Solid Dosage Form Drug Market Size YoY Growth 2018-2034
7.2 EMEA Solid Dosage Form Drug Market Size by Type
7.2.1 EMEA Solid Dosage Form Drug Market Size by Type (2018-2023)
7.2.2 EMEA Solid Dosage Form Drug Market Size by Type (2024-2034)
7.2.3 EMEA Solid Dosage Form Drug Market Share by Type (2018-2034)
7.3 EMEA Solid Dosage Form Drug Market Size by Application
7.3.1 EMEA Solid Dosage Form Drug Market Size by Application (2018-2023)
7.3.2 EMEA Solid Dosage Form Drug Market Size by Application (2024-2034)
7.3.3 EMEA Solid Dosage Form Drug Market Share by Application (2018-2034)
7.4 EMEA Solid Dosage Form Drug Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Solid Dosage Form Drug Market Size YoY Growth 2018-2034
8.2 China Solid Dosage Form Drug Market Size by Type
8.2.1 China Solid Dosage Form Drug Market Size by Type (2018-2023)
8.2.2 China Solid Dosage Form Drug Market Size by Type (2024-2034)
8.2.3 China Solid Dosage Form Drug Market Share by Type (2018-2034)
8.3 China Solid Dosage Form Drug Market Size by Application
8.3.1 China Solid Dosage Form Drug Market Size by Application (2018-2023)
8.3.2 China Solid Dosage Form Drug Market Size by Application (2024-2034)
8.3.3 China Solid Dosage Form Drug Market Share by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Solid Dosage Form Drug Market Size YoY Growth 2018-2034
9.2 APAC Solid Dosage Form Drug Market Size by Type
9.2.1 APAC Solid Dosage Form Drug Market Size by Type (2018-2023)
9.2.2 APAC Solid Dosage Form Drug Market Size by Type (2024-2034)
9.2.3 APAC Solid Dosage Form Drug Market Share by Type (2018-2034)
9.3 APAC Solid Dosage Form Drug Market Size by Application
9.3.1 APAC Solid Dosage Form Drug Market Size by Application (2018-2023)
9.3.2 APAC Solid Dosage Form Drug Market Size by Application (2024-2034)
9.3.3 APAC Solid Dosage Form Drug Market Share by Application (2018-2034)
9.4 APAC Solid Dosage Form Drug Market Facts & Figures by Country (2018, 2024 & 2034)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Johnson & Johnson
10.1.1 Johnson & Johnson Company Details
10.1.2 Johnson & Johnson Business Overview
10.1.3 Johnson & Johnson Solid Dosage Form Drug Introduction
10.1.4 Johnson & Johnson Revenue in Solid Dosage Form Drug Business (2018-2023)
10.1.5 Johnson & Johnson Recent Development
10.2 Novartis
10.2.1 Novartis Company Details
10.2.2 Novartis Business Overview
10.2.3 Novartis Solid Dosage Form Drug Introduction
10.2.4 Novartis Revenue in Solid Dosage Form Drug Business (2018-2023)
10.2.5 Novartis Recent Development
10.3 Roche
10.3.1 Roche Company Details
10.3.2 Roche Business Overview
10.3.3 Roche Solid Dosage Form Drug Introduction
10.3.4 Roche Revenue in Solid Dosage Form Drug Business (2018-2023)
10.3.5 Roche Recent Development
10.4 AbbVie
10.4.1 AbbVie Company Details
10.4.2 AbbVie Business Overview
10.4.3 AbbVie Solid Dosage Form Drug Introduction
10.4.4 AbbVie Revenue in Solid Dosage Form Drug Business (2018-2023)
10.4.5 AbbVie Recent Development
10.5 Merck & Co.
10.5.1 Merck & Co. Company Details
10.5.2 Merck & Co. Business Overview
10.5.3 Merck & Co. Solid Dosage Form Drug Introduction
10.5.4 Merck & Co. Revenue in Solid Dosage Form Drug Business (2018-2023)
10.5.5 Merck & Co. Recent Development
10.6 Bristol Myers Squibb
10.6.1 Bristol Myers Squibb Company Details
10.6.2 Bristol Myers Squibb Business Overview
10.6.3 Bristol Myers Squibb Solid Dosage Form Drug Introduction
10.6.4 Bristol Myers Squibb Revenue in Solid Dosage Form Drug Business (2018-2023)
10.6.5 Bristol Myers Squibb Recent Development
10.7 GlaxoSmithKline
10.7.1 GlaxoSmithKline Company Details
10.7.2 GlaxoSmithKline Business Overview
10.7.3 GlaxoSmithKline Solid Dosage Form Drug Introduction
10.7.4 GlaxoSmithKline Revenue in Solid Dosage Form Drug Business (2018-2023)
10.7.5 GlaxoSmithKline Recent Development
10.8 Pfizer
10.8.1 Pfizer Company Details
10.8.2 Pfizer Business Overview
10.8.3 Pfizer Solid Dosage Form Drug Introduction
10.8.4 Pfizer Revenue in Solid Dosage Form Drug Business (2018-2023)
10.8.5 Pfizer Recent Development
10.9 Sanofi
10.9.1 Sanofi Company Details
10.9.2 Sanofi Business Overview
10.9.3 Sanofi Solid Dosage Form Drug Introduction
10.9.4 Sanofi Revenue in Solid Dosage Form Drug Business (2018-2023)
10.9.5 Sanofi Recent Development
10.10 Takeda
10.10.1 Takeda Company Details
10.10.2 Takeda Business Overview
10.10.3 Takeda Solid Dosage Form Drug Introduction
10.10.4 Takeda Revenue in Solid Dosage Form Drug Business (2018-2023)
10.10.5 Takeda Recent Development
10.11 AstraZeneca
10.11.1 AstraZeneca Company Details
10.11.2 AstraZeneca Business Overview
10.11.3 AstraZeneca Solid Dosage Form Drug Introduction
10.11.4 AstraZeneca Revenue in Solid Dosage Form Drug Business (2018-2023)
10.11.5 AstraZeneca Recent Development
10.12 Bayer
10.12.1 Bayer Company Details
10.12.2 Bayer Business Overview
10.12.3 Bayer Solid Dosage Form Drug Introduction
10.12.4 Bayer Revenue in Solid Dosage Form Drug Business (2018-2023)
10.12.5 Bayer Recent Development
10.13 Eli Lilly & Co.
10.13.1 Eli Lilly & Co. Company Details
10.13.2 Eli Lilly & Co. Business Overview
10.13.3 Eli Lilly & Co. Solid Dosage Form Drug Introduction
10.13.4 Eli Lilly & Co. Revenue in Solid Dosage Form Drug Business (2018-2023)
10.13.5 Eli Lilly & Co. Recent Development
10.14 Gilead Sciences
10.14.1 Gilead Sciences Company Details
10.14.2 Gilead Sciences Business Overview
10.14.3 Gilead Sciences Solid Dosage Form Drug Introduction
10.14.4 Gilead Sciences Revenue in Solid Dosage Form Drug Business (2018-2023)
10.14.5 Gilead Sciences Recent Development
10.15 Amgen
10.15.1 Amgen Company Details
10.15.2 Amgen Business Overview
10.15.3 Amgen Solid Dosage Form Drug Introduction
10.15.4 Amgen Revenue in Solid Dosage Form Drug Business (2018-2023)
10.15.5 Amgen Recent Development
10.16 Teva
10.16.1 Teva Company Details
10.16.2 Teva Business Overview
10.16.3 Teva Solid Dosage Form Drug Introduction
10.16.4 Teva Revenue in Solid Dosage Form Drug Business (2018-2023)
10.16.5 Teva Recent Development
10.17 Boehringer Ingelheim
10.17.1 Boehringer Ingelheim Company Details
10.17.2 Boehringer Ingelheim Business Overview
10.17.3 Boehringer Ingelheim Solid Dosage Form Drug Introduction
10.17.4 Boehringer Ingelheim Revenue in Solid Dosage Form Drug Business (2018-2023)
10.17.5 Boehringer Ingelheim Recent Development
10.18 Biogen
10.18.1 Biogen Company Details
10.18.2 Biogen Business Overview
10.18.3 Biogen Solid Dosage Form Drug Introduction
10.18.4 Biogen Revenue in Solid Dosage Form Drug Business (2018-2023)
10.18.5 Biogen Recent Development
10.19 Astellas
10.19.1 Astellas Company Details
10.19.2 Astellas Business Overview
10.19.3 Astellas Solid Dosage Form Drug Introduction
10.19.4 Astellas Revenue in Solid Dosage Form Drug Business (2018-2023)
10.19.5 Astellas Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details

List of Figure

List of Tables
Table 1. Solid Dosage Form Drug Market Size United States VS Global, CAGR (2018 VS 2024 VS 2034)
Table 2. Solid Dosage Form Drug Market Trends
Table 3. Solid Dosage Form Drug Market Drivers
Table 4. Solid Dosage Form Drug Market Challenges
Table 5. Solid Dosage Form Drug Market Restraints
Table 6. Global Solid Dosage Form Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. United States Solid Dosage Form Drug Market Size by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Solid Dosage Form Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. United States Solid Dosage Form Drug Market Size by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Companies of Solid Dosage Form Drug, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Solid Dosage Form Drug Revenue by Player, (US$ Million), 2018-2023
Table 12. Global Solid Dosage Form Drug Revenue Share by Player, 2018-2023
Table 13. Global Solid Dosage Form Drug Companies Market Concentration Ratio (CR5 and HHI)
Table 14. Global Solid Dosage Form Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Dosage Form Drug as of 2024)
Table 15. Global Key Players of Solid Dosage Form Drug, Headquarters and Area Served
Table 16. Global Key Players of Solid Dosage Form Drug, Product and Application
Table 17. Global Key Players of Solid Dosage Form Drug, Date of Enter into This Industry
Table 18. Companies Mergers & Acquisitions, Expansion Plans
Table 19. Key Players of Solid Dosage Form Drug in United States, Ranked by Revenue (2024) & (US$ Million)
Table 20. United States Solid Dosage Form Drug Revenue by Players, (US$ Million), 2021, 2024 & 2023
Table 21. United States Solid Dosage Form Drug Revenue Share by Players, 2021, 2024 & 2023
Table 22. Global Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 23. Global Solid Dosage Form Drug Market Size by Region (2018-2023) & (US$ Million)
Table 24. Global Solid Dosage Form Drug Market Size Forecast by Region (2024-2034) & (US$ Million)
Table 25. Americas Solid Dosage Form Drug Market Size by Type (2018-2023) & (US$ Million)
Table 26. Americas Solid Dosage Form Drug Market Size by Type (2024-2034) & (US$ Million)
Table 27. Americas Solid Dosage Form Drug Market Size by Application (2018-2023) & (US$ Million)
Table 28. Americas Solid Dosage Form Drug Market Size by Application (2024-2034) & (US$ Million)
Table 29. Americas Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 30. Americas Solid Dosage Form Drug Market Size by Country (2018-2023) & (US$ Million)
Table 31. Americas Solid Dosage Form Drug Market Size by Country (2024-2034) & (US$ Million)
Table 32. EMEA Solid Dosage Form Drug Market Size by Type (2018-2023) & (US$ Million)
Table 33. EMEA Solid Dosage Form Drug Market Size by Type (2024-2034) & (US$ Million)
Table 34. EMEA Solid Dosage Form Drug Market Size by Application (2018-2023) & (US$ Million)
Table 35. EMEA Solid Dosage Form Drug Market Size by Application (2024-2034) & (US$ Million)
Table 36. EMEA Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 37. EMEA Solid Dosage Form Drug Market Size by Country (2018-2023) & (US$ Million)
Table 38. EMEA Solid Dosage Form Drug Market Size by Country (2024-2034) & (US$ Million)
Table 39. China Solid Dosage Form Drug Market Size by Type (2018-2023) & (US$ Million)
Table 40. China Solid Dosage Form Drug Market Size by Type (2024-2034) & (US$ Million)
Table 41. China Solid Dosage Form Drug Market Size by Application (2018-2023) & (US$ Million)
Table 42. China Solid Dosage Form Drug Market Size by Application (2024-2034) & (US$ Million)
Table 43. China Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. APAC Solid Dosage Form Drug Market Size by Type (2018-2023) & (US$ Million)
Table 45. APAC Solid Dosage Form Drug Market Size by Type (2024-2034) & (US$ Million)
Table 46. APAC Solid Dosage Form Drug Market Size by Application (2018-2023) & (US$ Million)
Table 47. APAC Solid Dosage Form Drug Market Size by Application (2024-2034) & (US$ Million)
Table 48. APAC Solid Dosage Form Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 49. APAC Solid Dosage Form Drug Market Size by Region (2018-2023) & (US$ Million)
Table 50. APAC Solid Dosage Form Drug Market Size by Region (2024-2034) & (US$ Million)
Table 51. Johnson & Johnson Company Details
Table 52. Johnson & Johnson Business Overview
Table 53. Johnson & Johnson Solid Dosage Form Drug Product
Table 54. Johnson & Johnson Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 55. Johnson & Johnson Recent Development
Table 56. Novartis Company Details
Table 57. Novartis Business Overview
Table 58. Novartis Solid Dosage Form Drug Product
Table 59. Novartis Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 60. Novartis Recent Development
Table 61. Roche Company Details
Table 62. Roche Business Overview
Table 63. Roche Solid Dosage Form Drug Product
Table 64. Roche Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. AbbVie Company Details
Table 67. AbbVie Business Overview
Table 68. AbbVie Solid Dosage Form Drug Product
Table 69. AbbVie Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 70. AbbVie Recent Development
Table 71. Merck & Co. Company Details
Table 72. Merck & Co. Business Overview
Table 73. Merck & Co. Solid Dosage Form Drug Product
Table 74. Merck & Co. Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 75. Merck & Co. Recent Development
Table 76. Bristol Myers Squibb Company Details
Table 77. Bristol Myers Squibb Business Overview
Table 78. Bristol Myers Squibb Solid Dosage Form Drug Product
Table 79. Bristol Myers Squibb Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 80. Bristol Myers Squibb Recent Development
Table 81. GlaxoSmithKline Company Details
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Solid Dosage Form Drug Product
Table 84. GlaxoSmithKline Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 85. GlaxoSmithKline Recent Development
Table 86. Pfizer Company Details
Table 87. Pfizer Business Overview
Table 88. Pfizer Solid Dosage Form Drug Product
Table 89. Pfizer Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 90. Pfizer Recent Development
Table 91. Sanofi Company Details
Table 92. Sanofi Business Overview
Table 93. Sanofi Solid Dosage Form Drug Product
Table 94. Sanofi Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 95. Sanofi Recent Development
Table 96. Takeda Company Details
Table 97. Takeda Business Overview
Table 98. Takeda Solid Dosage Form Drug Product
Table 99. Takeda Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 100. Takeda Recent Development
Table 101. AstraZeneca Company Details
Table 102. AstraZeneca Business Overview
Table 103. AstraZeneca Solid Dosage Form Drug Product
Table 104. AstraZeneca Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Bayer Company Details
Table 107. Bayer Business Overview
Table 108. Bayer Solid Dosage Form Drug Product
Table 109. Bayer Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 110. Bayer Recent Development
Table 111. Eli Lilly & Co. Company Details
Table 112. Eli Lilly & Co. Business Overview
Table 113. Eli Lilly & Co. Solid Dosage Form Drug Product
Table 114. Eli Lilly & Co. Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 115. Eli Lilly & Co. Recent Development
Table 116. Gilead Sciences Company Details
Table 117. Gilead Sciences Business Overview
Table 118. Gilead Sciences Solid Dosage Form Drug Product
Table 119. Gilead Sciences Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 120. Gilead Sciences Recent Development
Table 121. Amgen Company Details
Table 122. Amgen Business Overview
Table 123. Amgen Solid Dosage Form Drug Product
Table 124. Amgen Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 125. Amgen Recent Development
Table 126. Teva Company Details
Table 127. Teva Business Overview
Table 128. Teva Solid Dosage Form Drug Product
Table 129. Teva Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 130. Teva Recent Development
Table 131. Boehringer Ingelheim Company Details
Table 132. Boehringer Ingelheim Business Overview
Table 133. Boehringer Ingelheim Solid Dosage Form Drug Product
Table 134. Boehringer Ingelheim Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 135. Boehringer Ingelheim Recent Development
Table 136. Biogen Company Details
Table 137. Biogen Business Overview
Table 138. Biogen Solid Dosage Form Drug Product
Table 139. Biogen Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 140. Biogen Recent Development
Table 141. Astellas Company Details
Table 142. Astellas Business Overview
Table 143. Astellas Solid Dosage Form Drug Product
Table 144. Astellas Revenue in Solid Dosage Form Drug Business (2018-2023) & (US$ Million)
Table 145. Astellas Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Solid Dosage Form Drug Product Picture
Figure 2. Global Solid Dosage Form Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Solid Dosage Form Drug Market Size 2018-2034 (US$ Million)
Figure 4. United States Solid Dosage Form Drug Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 5. United States Solid Dosage Form Drug Market Size 2018-2034 (US$ Million)
Figure 6. United States Solid Dosage Form Drug Market Share in Global 2018-2034
Figure 7. Solid Dosage Form Drug Report Years Considered
Figure 8. Product Picture of Tablet
Figure 9. Product Picture of Capsules
Figure 10. Product Picture of Other
Figure 11. Global Solid Dosage Form Drug Market Share by Type in 2024 & 2034
Figure 12. Global Solid Dosage Form Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 13. Global Solid Dosage Form Drug Market Share by Type (2018-2034)
Figure 14. United States Solid Dosage Form Drug Market Share by Type in 2024 & 2034
Figure 15. United States Solid Dosage Form Drug Market Size by Type (2018-2034) & (US$ Million)
Figure 16. United States Solid Dosage Form Drug Market Share by Type (2018-2034)
Figure 17. Product Picture of Hospital
Figure 18. Product Picture of Retail Pharmacy
Figure 19. Product Picture of Other
Figure 20. Global Solid Dosage Form Drug Market Share by Application in 2024 & 2034
Figure 21. Global Solid Dosage Form Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 22. Global Solid Dosage Form Drug Market Share by Application (2018-2034)
Figure 23. United States Solid Dosage Form Drug Market Share by Application in 2024 & 2034
Figure 24. United States Solid Dosage Form Drug Market Size by Application (2018-2034) & (US$ Million)
Figure 25. United States Solid Dosage Form Drug Market Share by Application (2018-2034)
Figure 26. The Top 5 and 10 Largest Companies of Solid Dosage Form Drug in the World: Market Share by Solid Dosage Form Drug Revenue in 2024
Figure 27. Global Solid Dosage Form Drug Market Size Market Share by Region: 2018 VS 2024 VS 2034
Figure 28. Global Solid Dosage Form Drug Market Share by Region (2018-2034)
Figure 29. Americas Solid Dosage Form Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 30. Americas Solid Dosage Form Drug Market Share by Type (2018-2034)
Figure 31. Americas Solid Dosage Form Drug Market Share by Application (2018-2034)
Figure 32. United States Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 33. Canada Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 34. Mexico Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 35. Brazil Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 36. EMEA Solid Dosage Form Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 37. EMEA Solid Dosage Form Drug Market Share by Type (2018-2034)
Figure 38. EMEA Solid Dosage Form Drug Market Share by Application (2018-2034)
Figure 39. Europe Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 40. Middle East Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 41. Africa Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 42. China Solid Dosage Form Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 43. China Solid Dosage Form Drug Market Share by Type (2018-2034)
Figure 44. China Solid Dosage Form Drug Market Share by Application (2018-2034)
Figure 45. APAC Solid Dosage Form Drug Market Size Growth Rate 2018-2034 (US$ Million)
Figure 46. APAC Solid Dosage Form Drug Market Share by Type (2018-2034)
Figure 47. APAC Solid Dosage Form Drug Market Share by Application (2018-2034)
Figure 48. Japan Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 49. South Korea Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 50. China Taiwan Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 51. Southeast Asia Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 52. India Solid Dosage Form Drug Market Size Growth Rate (2018-2034) & (US$ Million)
Figure 53. Johnson & Johnson Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 54. Novartis Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 55. Roche Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 56. AbbVie Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 57. Merck & Co. Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 58. Bristol Myers Squibb Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 60. Pfizer Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 61. Sanofi Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 62. Takeda Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 63. AstraZeneca Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 64. Bayer Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 65. Eli Lilly & Co. Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 66. Gilead Sciences Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 67. Amgen Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 68. Teva Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 69. Boehringer Ingelheim Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 70. Biogen Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 71. Astellas Revenue Growth Rate in Solid Dosage Form Drug Business (2018-2023)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries